BIT 1.05% 9.6¢ biotron limited

News: Biotron's Hep C drug candidate phase 2a tri, page-2

  1. 122 Posts.
    lightbulb Created with Sketch. 1
    re: News: Biotron's Hep C drug candidate phas... Very, very exciting prospect here IMO (for the hearing impaired)

    Dr.Michelle Miller CEO

    "regulatory authorities such as the FDA in the US have been really clear in saying they are very keen to see trials quickly, and development through the market quickly, in difficult to treat hepatitis C populations and one of those groups is the HIV and HCV co-infected populations. Up to 30% of HIV patients are also are also infected with Hep C".

    "Biotron is in the unique position of having this drug BIT-225 which has activity against both HIV and Hepatitis C".

    Bring on the deal/s !!!

watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Mkt cap ! $66.68M
Open High Low Value Volume
9.5¢ 9.8¢ 9.4¢ $252.1K 2.620M

Buyers (Bids)

No. Vol. Price($)
2 218028 9.5¢

Sellers (Offers)

Price($) Vol. No.
9.6¢ 30218 2
View Market Depth
Last trade - 14.08pm 28/05/2020 (20 minute delay) ?
0.001 ( 1.06 %)
Open High Low Volume
9.4¢ 9.8¢ 9.3¢ 530848
Last updated 14.18pm 28/05/2020 (live) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.